SlideShare a Scribd company logo
Cases application on
Arthropod borne diseases
By Dalia Bahaa
Under supervision of
Prof Dr Mona Aboserea
Faculty of medicine –Zagazig University
1-Mykel is 35 years old wood cutter in
Africa, he complained from sudden onset of
fever, headache, muscle pain, vomiting and
prostration, on examination the pulse was
slow and there was some jaundice
a)What is the possible diagnosis
 Yellow Fever
b) How can you confirm
 A. Symptoms
 B. Travel history
 C. Lab investigations as:
*Isolation of the virus from blood
*Demonstration of viral antigen in the blood by ELISA.
*Demonstration of viral genome in blood and liver tissue by PCR.
*Serologic diagnosis by demonstration of specific IgM in early sera or rise in titre of
specific antibodies
c)If the traveler comes to Egypt, what are
the measures that should be taken?
 International measures: It is one of the quarantinable diseases and
the following measures should be done to prevent introduction of yellow
fever from endemic area (Yellow Fever belt) into receptive area (areas
free of yellow fever, but the vector is present and the population is
susceptible e.g. in Egypt) :
 Notification within 24 hours by governments to WHO.
 Disinfection of any aircraft leaving an endemic area for receptive area,
by aerosol spray of suitable insecticide, shortly before departure and
also on arrival
 Valid vaccination certificate:
a. Is required from all international travelers including children coming from
or going to endemic areas "Yellow Fever belt."
b. Validity starts 10 days after primo-vaccination and lasts for 10 years.
c. Validity starts on same day after re-vaccination and lasts for 10 years.
d. If no certificate is available: traveler is isolated for 6 days from date of
leaving endemic area.
e. If traveler arrives before 10 days of vaccination, i.e. certificate is not valid
yet: traveler is isolated until certificate becomes valid or until the end of
international incubation period calculated from the day of leaving the last
endemic area.
f. Traveler is quarantined in mosquito-proof accommodation in airport.
g. This certificate is required by many countries including Egypt
2-A 50 y old male patient, from Qaliobyia, suffers
from progressive enlargement of his limb. By
history he was suffering from repeated attacks of
enlarged painful lymph nodes in the past 10 years
a)What is possible diagnosis?
 Filariasis (Bancroftian filariasis)
b) How can the disease be transmitted?
 By the bite of infective mosquito.
 In Egypt: female Culex pipiens, but it could be transmitted by the bite of Anopheles
gambia and Aedes. When the mosquito bites an individual the larvae can enter the
punctured skin
 Many mosquito bites over several months to years are needed to get lymphatic
filariasis.
 People living for a long time in tropical or sub-tropical areas where the disease is
common are at the greatest risk for infection. Short-term tourists have a very low
risk
c)How can you confirm diagnosis
 Identification of microfilariae in a blood smear by microscopic examination
during maximum presence (nocturnal), thick smear should be made and
stained with Giemsa
 *Patients with active filarial infection typically have elevated levels of antifilarial
IgG4 in the blood and these can be detected using routine assays.
 *Because lymphedema may develop many years after infection, lab tests are
most likely to be negative with these patients
d)What is the treatment
Patients currently infected with the parasite
 DEC (Banocid, Hetrazan). Treatment results in rapid suppression of most or all
microfilaria from the blood, and some adult worms. Low level of microfilaria may reappear
after treatment. Therefore, treatment must usually be repeated at yearly interval, and
laboratory follow up should be done for treated cases.
 Ivermectin kills only the microfilariae, but not the adult worm; the adult worm is
responsible for the pathology of lymphedema and hydrocele.
 Some studies have shown adult worm killing with treatment with Doxycycline
(200mg/day for 4–6 weeks).
Patients with clinical symptoms
 Lymphedema and elephantiasis are NOT indications for DEC treatment because most
people with lymphedema are not actively infected with the filarial parasite.
 The treatment for hydrocele is surgery
e)How can you prevent the disease
 General:
1 .Environmental sanitation:
a. Eradication or control of mosquito vector
b.​Human protection against mosquitoes: e.g. protective clothing, bed nets, repellents and stay
indoor.
The mosquitoes that carry the microscopic worms usually bite between the hours of dusk and
dawn. If you live in an area with lymphatic filariasis.
2 .Health education:About modes of transmission and Protection against mosquito bites to
reduce exposure to infection.
 Specific:
 Mass drug administration:
In areas where lymphatic filariasis is endemic: WHO currently recommends mass drug
administration, as an annual single dose, of combinations of diethylcarbamizine citrate (DEC)
6mg/kg body weight with 400 mg of albendazole for 4-6 years, or the regular use of DEC-
medicated cooking salt for 1-2 years. Mass administration of these drugs has the two fold
purpose of preventing future cases of lymphatic filariasis and helping those people who are
already suffering from the disease
3-Ahmed is football player return with his
team from championship in Ethiopia with
sudden onset of fever for 3-5 days, intense
headache, rash. Epistaxis, gum bleeding
and petechiae
a)What is possible diagnosis
 Dengue fever(Break Bone Fever)
b) How can the disease be transmitted
 bite of infective Aedes aegypti mosquito
C) What is DD
 1-yellow fever
 2 -Rift valley fever
 3-Encephilitis
d)How can you prevent the disease
 General Prevention​
1) Environmental sanitation:
A) Eradication or control of mosquito vector by:
i. Anti-larval and anti-pupal measures
ii. Anti-adult measures
iii. Jungle mosquitoes: control is impractical.
Human protection against mosquitoes: e.g. protective clothing, bed nets, repellents and stay
indoors.
2 )Health education about modes of transmission to reduce exposure to infection.
 Specific: Dengue fever vaccine
4-A butcher in El Sharkia come to hospital
with fever, influenza like picture and he was
diagnosed as influenza and take some fluids
and antipyretic then return to home after
few days he show hemorrhagic in gum,
impaired liver function, vision problem and
neurological manifestation
a)What is possible diagnosis?
 Q fever
b) Causative agen?
 Coxiella Burnetti
C).Reservoir?
 Small wild mammals,cattle, sheep, goats, birds and man.
D)Mode of transmission?
-Occupational as veterinarians, meat processing, sheep and dairy workers and
farmers through direct contact with domestic animals especially while animals are
giving birth.
 -Air borne by rickettsia present in dust contaminated by placental tissues, birth
fluids and excreta of infected animals.
 -Ingestion of raw milk
e)How can you prevent the disease
General prevention:
 Control of the disease in domestic animals either by vaccination or by antibiotics.
 Milk pasteurized at high temperature.
 Health education: about necessity for adequate disinfection and disposal of animal
products.
Specific prevention:
 Immunization:
By inactivated vaccine Q 34, given in 1ml dose as 3 weekly subcutaneous. For high
risk workers as laboratory workers and workers in contacts with animals and animal'
products
5-Many students in slum area come to
unit with abrupt onset of high fever,
rigors, body aches. Cyanotic face, dull
and confused. They show skin rash on
folds of axilla, anterior part of forearms
then trunk and back.
a)What is possible diagnosis?
Epidemic typhus
b)How can you confirm diagnosis?
 -suggestive clinical picture
 -lab investigation as weil-felix reaction (agglutination
test).
c)How can you prevent and control the disease?
General prevention:
 -Health education for personal cleanliness.
 -Delousing of population by washing facilities & dusting with a suitable insecticide.
Specific prevention:
 typhus vaccine (live attenuated vaccine), Madrid E typhus vaccine a single IM dose, giving
immunity for 5 years.
*Cases:
 -Notification to LHO.
 -Isolation in hospital after dusting.
 -Terminal disinfection by dusting (to kill any lice) & steam disinfection for clothes & bedding
(to kill rickettsia).
 -Treatment by tetracycline 500 mg / 6hs for seven days.
 -Release after clinical recovery of the case.
*Contacts :-
 -Delousing by bathing & dusting.
 -Surveillance for 2 weeks, for case-finding.
*Epidemic measures :-
 -Delousing of confined groups and underdeveloped communities
by washing facilities & dusting.
 -Vaccination of high risk groups.
 -Searching for the source of infection
6-Emad is a cattle merchant return from Brazil
from one month he came to hospital with fever,
chills, malaise, headache, nausea, lassitude,
muscle and joint pain, rigor sensation and the
fever rapidly rising ending by profuse sweating.
The cycle of fever, chills, sweating is repeated
daily
a)What’s possible diagnosis?
 Possible diagnosis: Malaria
b)How to Confirm diagnosis?
by:
 •Demonstration of malaria parasites in thick blood film.
 •Repeated microscopic examination every 12-24 hours may be necessary to
 cover all parasite species.
 •Several tests have been developed: The most promising are:
-Rapid diagnostic tests that detect plasmoidal antigens in the blood.
-PCR is the most sensitive method.
-Demonstrating antibodies which appear after first week of infection but may persist for
years denoting past malaria infection.
C) What are the Complications?
 -Anemia.
 -Splenomegaly.
 -Abortion and fetal infection.
 -Falciparum malaria may be associated with respiratory distress, jaundice,
liver failure, encephalopathy, pulmonary and cerebral edema, coma and death.
D)Prevention& Control:
1 .General preventive measures: of arthropod borne disease.
 -Environmental sanitation, vector control and Health education:
*Elimination of the breeding sites of mosquito by filling of swamps, marches and small
collection of water.
*Eradication of larval stages by spraying crude oil and larvicides on water surface.
*Destruction of adult mosquitoes by using suitable insecticides (liquid aerosol, pyrethrium).
 -Human protection:
*Screening of windows and doors, using bed nets and animal barrier between breeding
places and human habitation.
-using protective cloths.
-Apply of repellents to exposed skin between dusk
-Avoid going outdoors and down when anopheline mosquitoes commonly bite.
-Health education of the public, at risk groups and travelers for the mode of transmission,
protection from exposure and value of prophylaxis and treatment.
-Avoid taking blood from any individual giving history of malaria or a history of travel to, or
residence in, a malarious area
Specific measures:
 Chemoprophylaxis for international travelers going to endemic areas.
■Chloroquine or hydrroxy chloroquine 5 mg /kg /week or chloroquine phosphate
(500 mg for average adult).
■The drug must be continued for 4-6 weeks after leaving endemic areas.
■In areas with chloroquine-resistant P. falciparum, mefloquine is recommended
(5mg/kg/week) for adults, 1-2 week before travel, during stay and 4 weeks after
leaving the endemic area
Control:
 Case: Early case finding:
*By laboratory examination of clinically suspected persons.
*By periodic survey.
*Through malaria campaign.
Treatment: Using antimalarial drugs as chloroquine or mefloquine etc.
 Contacts:• Investigation for early case findings.
7-Female child in a village in upper Egypt
come with fever, headache, skeletal and
abdominal tenderness with palpable liver
and spleen, jaundice and purpura occur.
Hyperpyrexia, hypotension after
examination doctor found lice in her scalp
A) what is Possible diagnosis?
 LOUSE- BORNE RELAPSING FEVER
b) How to Confirm of diagnosis?
 by: Dark ground illumination or stained blood films.
Intraperitoneal inoculation or culture in lab animals
C) what is the Prognosis:
 Hyperpyrexia, hypotension and cardiac failure
D)What’s the prevention and control?
General prevention:
 )Delousing by residual insecticide powder as in typhus.
 )Protection of susceptible: use of repellents and protective clothes.
Specific prevention:
 chemoprophylaxis with tetracycline after exposure
Control
Cases:
 Notification : to LHO
 Isolation: precautions with blood and body fluids.
 Concurrent disinfection : none
 Treatment: procaine penicillin injection followed by oral tetracycline
Contacts: Case findings.
Epidemic measures:
 Apply insecticides to clothes and houses
Thank you

More Related Content

What's hot

Zika virus outbreak,2016
Zika virus outbreak,2016Zika virus outbreak,2016
Zika virus outbreak,2016
Ruhul Amin
 
Ebola viral disease--------- prevention
Ebola viral disease--------- preventionEbola viral disease--------- prevention
Ebola viral disease--------- preventionladdha1962
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
Dr. Dharmendra Gahwai
 
Cancer Prevention
Cancer PreventionCancer Prevention
Cancer Prevention
Md Jahirul Islam Sojib
 
Occupational Cancer in the 21st century
Occupational Cancer in the 21st centuryOccupational Cancer in the 21st century
Occupational Cancer in the 21st century
ISGlobal Barcelona Institute for Global Health
 
Sexually Transmitted Diseases (STDs)
Sexually Transmitted Diseases (STDs)Sexually Transmitted Diseases (STDs)
Sexually Transmitted Diseases (STDs)
shyamsonecha
 
Sexually transmitted diseases
Sexually transmitted diseasesSexually transmitted diseases
Sexually transmitted diseases
Monika Devi NR
 
National Urban Health Mission
National Urban Health MissionNational Urban Health Mission
National Urban Health Mission
Dr Christa Maria Joel MBBS MPH MRSPH
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
Mohammad Ismail Zubair MD. MSc
 
Ebola virus
Ebola virusEbola virus
Ebola virus
RAVIKANTAMISHRA
 
Zika viral infection by Dr.T.V,Rao MD
Zika viral infection by Dr.T.V,Rao MDZika viral infection by Dr.T.V,Rao MD
Zika viral infection by Dr.T.V,Rao MD
Society for Microbiology and Infection care
 
Fundamentals of bioethics and biosafety
Fundamentals of bioethics and biosafetyFundamentals of bioethics and biosafety
Fundamentals of bioethics and biosafety
Mahmoud Bahnasi
 
PULSE POLIO ,IMMUNIZATION PROGRAMME.pptx
PULSE POLIO ,IMMUNIZATION PROGRAMME.pptxPULSE POLIO ,IMMUNIZATION PROGRAMME.pptx
PULSE POLIO ,IMMUNIZATION PROGRAMME.pptx
M.Josephin Dayana
 
Plague.pptx
Plague.pptxPlague.pptx
Plague.pptx
Dr Bushra Jabeen
 
Malaria ppt.
Malaria ppt.Malaria ppt.
Malaria ppt.
Lajina Ghimire
 
JAPANESE ENCEPHALITIS- OVERVIEW
JAPANESE ENCEPHALITIS- OVERVIEWJAPANESE ENCEPHALITIS- OVERVIEW
JAPANESE ENCEPHALITIS- OVERVIEW
Rohan Sahu
 
Sexually transmitted disease (stds)
Sexually transmitted disease (stds)Sexually transmitted disease (stds)
Sexually transmitted disease (stds)
DR MUKESH SAH
 

What's hot (20)

Zika virus outbreak,2016
Zika virus outbreak,2016Zika virus outbreak,2016
Zika virus outbreak,2016
 
Ebola viral disease--------- prevention
Ebola viral disease--------- preventionEbola viral disease--------- prevention
Ebola viral disease--------- prevention
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
 
Cancer Prevention
Cancer PreventionCancer Prevention
Cancer Prevention
 
Occupational Cancer in the 21st century
Occupational Cancer in the 21st centuryOccupational Cancer in the 21st century
Occupational Cancer in the 21st century
 
Outbreak Investigation
Outbreak InvestigationOutbreak Investigation
Outbreak Investigation
 
Disease eradication
Disease eradicationDisease eradication
Disease eradication
 
Sexually Transmitted Diseases (STDs)
Sexually Transmitted Diseases (STDs)Sexually Transmitted Diseases (STDs)
Sexually Transmitted Diseases (STDs)
 
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigation
 
Sexually transmitted diseases
Sexually transmitted diseasesSexually transmitted diseases
Sexually transmitted diseases
 
National Urban Health Mission
National Urban Health MissionNational Urban Health Mission
National Urban Health Mission
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Ebola virus
Ebola virusEbola virus
Ebola virus
 
Zika viral infection by Dr.T.V,Rao MD
Zika viral infection by Dr.T.V,Rao MDZika viral infection by Dr.T.V,Rao MD
Zika viral infection by Dr.T.V,Rao MD
 
Fundamentals of bioethics and biosafety
Fundamentals of bioethics and biosafetyFundamentals of bioethics and biosafety
Fundamentals of bioethics and biosafety
 
PULSE POLIO ,IMMUNIZATION PROGRAMME.pptx
PULSE POLIO ,IMMUNIZATION PROGRAMME.pptxPULSE POLIO ,IMMUNIZATION PROGRAMME.pptx
PULSE POLIO ,IMMUNIZATION PROGRAMME.pptx
 
Plague.pptx
Plague.pptxPlague.pptx
Plague.pptx
 
Malaria ppt.
Malaria ppt.Malaria ppt.
Malaria ppt.
 
JAPANESE ENCEPHALITIS- OVERVIEW
JAPANESE ENCEPHALITIS- OVERVIEWJAPANESE ENCEPHALITIS- OVERVIEW
JAPANESE ENCEPHALITIS- OVERVIEW
 
Sexually transmitted disease (stds)
Sexually transmitted disease (stds)Sexually transmitted disease (stds)
Sexually transmitted disease (stds)
 

Similar to Cases of-arthropod-borne-diseases

Epidemiology of yellow fever
Epidemiology of yellow feverEpidemiology of yellow fever
Epidemiology of yellow fever
Namita Batra
 
Arthropode infection
Arthropode infectionArthropode infection
Arthropode infection
Dalia El-Shafei
 
Arthropod. borne part 1
Arthropod. borne  part 1Arthropod. borne  part 1
Arthropod. borne part 1
monaaboserea
 
Arthropod-born infections
Arthropod-born infectionsArthropod-born infections
Arthropod-born infections
Dalia El-Shafei
 
Feco-oral diseases.pdf
Feco-oral diseases.pdfFeco-oral diseases.pdf
Feco-oral diseases.pdf
AmanuelDina1
 
Crimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic FeverCrimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic Fever
Bhagawana Ram
 
Recent advances in malaria
Recent advances in malariaRecent advances in malaria
Recent advances in malaria
Daulal Chouhan
 
Chikungunya
ChikungunyaChikungunya
Chikungunya
Upendra Raj Dhakal
 
Yellow fever
Yellow feverYellow fever
Yellow fever
prajnyaelinar digal
 
Arthropod borne part 2
Arthropod borne part 2Arthropod borne part 2
Arthropod borne part 2
monaaboserea
 
Yellow fever
Yellow feverYellow fever
Yellow fever
tamil11
 
Yellow fever
Yellow feverYellow fever
Yellow fever
manasi moharana
 
Monkeypox Facts 2022.pdf
Monkeypox Facts 2022.pdfMonkeypox Facts 2022.pdf
Monkeypox Facts 2022.pdf
MelaniePaday1
 
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptxEPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
YogeswaranElangovan2
 
Monkeypox.pdf
Monkeypox.pdfMonkeypox.pdf
Monkeypox.pdf
Naya Hassan
 
dengue.pptx
dengue.pptxdengue.pptx
dengue.pptx
Mittal Rathod
 
3.INTESTINAL INFECTIONS.pptx
3.INTESTINAL INFECTIONS.pptx3.INTESTINAL INFECTIONS.pptx
3.INTESTINAL INFECTIONS.pptx
YogeswaranElangovan2
 
Viral food born infections
Viral food born infectionsViral food born infections
Viral food born infections
Dalia El-Shafei
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitisamitakashyap1
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
WaqarAli458508
 

Similar to Cases of-arthropod-borne-diseases (20)

Epidemiology of yellow fever
Epidemiology of yellow feverEpidemiology of yellow fever
Epidemiology of yellow fever
 
Arthropode infection
Arthropode infectionArthropode infection
Arthropode infection
 
Arthropod. borne part 1
Arthropod. borne  part 1Arthropod. borne  part 1
Arthropod. borne part 1
 
Arthropod-born infections
Arthropod-born infectionsArthropod-born infections
Arthropod-born infections
 
Feco-oral diseases.pdf
Feco-oral diseases.pdfFeco-oral diseases.pdf
Feco-oral diseases.pdf
 
Crimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic FeverCrimean Congo Hemorrhagic Fever
Crimean Congo Hemorrhagic Fever
 
Recent advances in malaria
Recent advances in malariaRecent advances in malaria
Recent advances in malaria
 
Chikungunya
ChikungunyaChikungunya
Chikungunya
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Arthropod borne part 2
Arthropod borne part 2Arthropod borne part 2
Arthropod borne part 2
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Monkeypox Facts 2022.pdf
Monkeypox Facts 2022.pdfMonkeypox Facts 2022.pdf
Monkeypox Facts 2022.pdf
 
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptxEPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
 
Monkeypox.pdf
Monkeypox.pdfMonkeypox.pdf
Monkeypox.pdf
 
dengue.pptx
dengue.pptxdengue.pptx
dengue.pptx
 
3.INTESTINAL INFECTIONS.pptx
3.INTESTINAL INFECTIONS.pptx3.INTESTINAL INFECTIONS.pptx
3.INTESTINAL INFECTIONS.pptx
 
Viral food born infections
Viral food born infectionsViral food born infections
Viral food born infections
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitis
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
 

More from monaaboserea

Prisoners' health
Prisoners' healthPrisoners' health
Prisoners' health
monaaboserea
 
Traveler medicine
Traveler medicineTraveler medicine
Traveler medicine
monaaboserea
 
Refugee &migrants health
Refugee &migrants healthRefugee &migrants health
Refugee &migrants health
monaaboserea
 
Arthropod borne mc qs
Arthropod borne  mc qsArthropod borne  mc qs
Arthropod borne mc qs
monaaboserea
 
Screening tests
Screening  testsScreening  tests
Screening tests
monaaboserea
 
Sampling
SamplingSampling
Sampling
monaaboserea
 
Risk assessment
Risk assessmentRisk assessment
Risk assessment
monaaboserea
 
Research methodology
Research methodologyResearch methodology
Research methodology
monaaboserea
 
Statistics
StatisticsStatistics
Statistics
monaaboserea
 
Ncds part 2
Ncds part 2Ncds part 2
Ncds part 2
monaaboserea
 
Non communicable diseases part 1
Non communicable diseases part 1Non communicable diseases part 1
Non communicable diseases part 1
monaaboserea
 
Mcqs general epidemiology
Mcqs   general epidemiologyMcqs   general epidemiology
Mcqs general epidemiology
monaaboserea
 
General epidemiology
General epidemiologyGeneral epidemiology
General epidemiology
monaaboserea
 
Disaster and-communicable-diseases
Disaster and-communicable-diseasesDisaster and-communicable-diseases
Disaster and-communicable-diseases
monaaboserea
 
Substance abuse
Substance abuseSubstance abuse
Substance abuse
monaaboserea
 
Mcqs food borne
Mcqs food borneMcqs food borne
Mcqs food borne
monaaboserea
 
Aids issues
Aids  issuesAids  issues
Aids issues
monaaboserea
 
Cases.on conatct infections
Cases.on conatct  infectionsCases.on conatct  infections
Cases.on conatct infections
monaaboserea
 
Air borne diseases
Air borne diseasesAir borne diseases
Air borne diseases
monaaboserea
 
Mcq contact diseseaes
Mcq contact diseseaesMcq contact diseseaes
Mcq contact diseseaes
monaaboserea
 

More from monaaboserea (20)

Prisoners' health
Prisoners' healthPrisoners' health
Prisoners' health
 
Traveler medicine
Traveler medicineTraveler medicine
Traveler medicine
 
Refugee &migrants health
Refugee &migrants healthRefugee &migrants health
Refugee &migrants health
 
Arthropod borne mc qs
Arthropod borne  mc qsArthropod borne  mc qs
Arthropod borne mc qs
 
Screening tests
Screening  testsScreening  tests
Screening tests
 
Sampling
SamplingSampling
Sampling
 
Risk assessment
Risk assessmentRisk assessment
Risk assessment
 
Research methodology
Research methodologyResearch methodology
Research methodology
 
Statistics
StatisticsStatistics
Statistics
 
Ncds part 2
Ncds part 2Ncds part 2
Ncds part 2
 
Non communicable diseases part 1
Non communicable diseases part 1Non communicable diseases part 1
Non communicable diseases part 1
 
Mcqs general epidemiology
Mcqs   general epidemiologyMcqs   general epidemiology
Mcqs general epidemiology
 
General epidemiology
General epidemiologyGeneral epidemiology
General epidemiology
 
Disaster and-communicable-diseases
Disaster and-communicable-diseasesDisaster and-communicable-diseases
Disaster and-communicable-diseases
 
Substance abuse
Substance abuseSubstance abuse
Substance abuse
 
Mcqs food borne
Mcqs food borneMcqs food borne
Mcqs food borne
 
Aids issues
Aids  issuesAids  issues
Aids issues
 
Cases.on conatct infections
Cases.on conatct  infectionsCases.on conatct  infections
Cases.on conatct infections
 
Air borne diseases
Air borne diseasesAir borne diseases
Air borne diseases
 
Mcq contact diseseaes
Mcq contact diseseaesMcq contact diseseaes
Mcq contact diseseaes
 

Recently uploaded

Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 

Recently uploaded (20)

Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

Cases of-arthropod-borne-diseases

  • 1. Cases application on Arthropod borne diseases By Dalia Bahaa Under supervision of Prof Dr Mona Aboserea Faculty of medicine –Zagazig University
  • 2. 1-Mykel is 35 years old wood cutter in Africa, he complained from sudden onset of fever, headache, muscle pain, vomiting and prostration, on examination the pulse was slow and there was some jaundice
  • 3. a)What is the possible diagnosis  Yellow Fever b) How can you confirm  A. Symptoms  B. Travel history  C. Lab investigations as: *Isolation of the virus from blood *Demonstration of viral antigen in the blood by ELISA. *Demonstration of viral genome in blood and liver tissue by PCR. *Serologic diagnosis by demonstration of specific IgM in early sera or rise in titre of specific antibodies
  • 4. c)If the traveler comes to Egypt, what are the measures that should be taken?  International measures: It is one of the quarantinable diseases and the following measures should be done to prevent introduction of yellow fever from endemic area (Yellow Fever belt) into receptive area (areas free of yellow fever, but the vector is present and the population is susceptible e.g. in Egypt) :  Notification within 24 hours by governments to WHO.  Disinfection of any aircraft leaving an endemic area for receptive area, by aerosol spray of suitable insecticide, shortly before departure and also on arrival
  • 5.  Valid vaccination certificate: a. Is required from all international travelers including children coming from or going to endemic areas "Yellow Fever belt." b. Validity starts 10 days after primo-vaccination and lasts for 10 years. c. Validity starts on same day after re-vaccination and lasts for 10 years. d. If no certificate is available: traveler is isolated for 6 days from date of leaving endemic area. e. If traveler arrives before 10 days of vaccination, i.e. certificate is not valid yet: traveler is isolated until certificate becomes valid or until the end of international incubation period calculated from the day of leaving the last endemic area. f. Traveler is quarantined in mosquito-proof accommodation in airport. g. This certificate is required by many countries including Egypt
  • 6. 2-A 50 y old male patient, from Qaliobyia, suffers from progressive enlargement of his limb. By history he was suffering from repeated attacks of enlarged painful lymph nodes in the past 10 years
  • 7. a)What is possible diagnosis?  Filariasis (Bancroftian filariasis) b) How can the disease be transmitted?  By the bite of infective mosquito.  In Egypt: female Culex pipiens, but it could be transmitted by the bite of Anopheles gambia and Aedes. When the mosquito bites an individual the larvae can enter the punctured skin  Many mosquito bites over several months to years are needed to get lymphatic filariasis.  People living for a long time in tropical or sub-tropical areas where the disease is common are at the greatest risk for infection. Short-term tourists have a very low risk
  • 8. c)How can you confirm diagnosis  Identification of microfilariae in a blood smear by microscopic examination during maximum presence (nocturnal), thick smear should be made and stained with Giemsa  *Patients with active filarial infection typically have elevated levels of antifilarial IgG4 in the blood and these can be detected using routine assays.  *Because lymphedema may develop many years after infection, lab tests are most likely to be negative with these patients
  • 9. d)What is the treatment Patients currently infected with the parasite  DEC (Banocid, Hetrazan). Treatment results in rapid suppression of most or all microfilaria from the blood, and some adult worms. Low level of microfilaria may reappear after treatment. Therefore, treatment must usually be repeated at yearly interval, and laboratory follow up should be done for treated cases.  Ivermectin kills only the microfilariae, but not the adult worm; the adult worm is responsible for the pathology of lymphedema and hydrocele.  Some studies have shown adult worm killing with treatment with Doxycycline (200mg/day for 4–6 weeks). Patients with clinical symptoms  Lymphedema and elephantiasis are NOT indications for DEC treatment because most people with lymphedema are not actively infected with the filarial parasite.  The treatment for hydrocele is surgery
  • 10. e)How can you prevent the disease  General: 1 .Environmental sanitation: a. Eradication or control of mosquito vector b.​Human protection against mosquitoes: e.g. protective clothing, bed nets, repellents and stay indoor. The mosquitoes that carry the microscopic worms usually bite between the hours of dusk and dawn. If you live in an area with lymphatic filariasis. 2 .Health education:About modes of transmission and Protection against mosquito bites to reduce exposure to infection.  Specific:  Mass drug administration: In areas where lymphatic filariasis is endemic: WHO currently recommends mass drug administration, as an annual single dose, of combinations of diethylcarbamizine citrate (DEC) 6mg/kg body weight with 400 mg of albendazole for 4-6 years, or the regular use of DEC- medicated cooking salt for 1-2 years. Mass administration of these drugs has the two fold purpose of preventing future cases of lymphatic filariasis and helping those people who are already suffering from the disease
  • 11. 3-Ahmed is football player return with his team from championship in Ethiopia with sudden onset of fever for 3-5 days, intense headache, rash. Epistaxis, gum bleeding and petechiae
  • 12. a)What is possible diagnosis  Dengue fever(Break Bone Fever) b) How can the disease be transmitted  bite of infective Aedes aegypti mosquito C) What is DD  1-yellow fever  2 -Rift valley fever  3-Encephilitis
  • 13. d)How can you prevent the disease  General Prevention​ 1) Environmental sanitation: A) Eradication or control of mosquito vector by: i. Anti-larval and anti-pupal measures ii. Anti-adult measures iii. Jungle mosquitoes: control is impractical. Human protection against mosquitoes: e.g. protective clothing, bed nets, repellents and stay indoors. 2 )Health education about modes of transmission to reduce exposure to infection.  Specific: Dengue fever vaccine
  • 14. 4-A butcher in El Sharkia come to hospital with fever, influenza like picture and he was diagnosed as influenza and take some fluids and antipyretic then return to home after few days he show hemorrhagic in gum, impaired liver function, vision problem and neurological manifestation
  • 15. a)What is possible diagnosis?  Q fever b) Causative agen?  Coxiella Burnetti C).Reservoir?  Small wild mammals,cattle, sheep, goats, birds and man. D)Mode of transmission? -Occupational as veterinarians, meat processing, sheep and dairy workers and farmers through direct contact with domestic animals especially while animals are giving birth.  -Air borne by rickettsia present in dust contaminated by placental tissues, birth fluids and excreta of infected animals.  -Ingestion of raw milk
  • 16. e)How can you prevent the disease General prevention:  Control of the disease in domestic animals either by vaccination or by antibiotics.  Milk pasteurized at high temperature.  Health education: about necessity for adequate disinfection and disposal of animal products. Specific prevention:  Immunization: By inactivated vaccine Q 34, given in 1ml dose as 3 weekly subcutaneous. For high risk workers as laboratory workers and workers in contacts with animals and animal' products
  • 17. 5-Many students in slum area come to unit with abrupt onset of high fever, rigors, body aches. Cyanotic face, dull and confused. They show skin rash on folds of axilla, anterior part of forearms then trunk and back.
  • 18. a)What is possible diagnosis? Epidemic typhus b)How can you confirm diagnosis?  -suggestive clinical picture  -lab investigation as weil-felix reaction (agglutination test).
  • 19. c)How can you prevent and control the disease? General prevention:  -Health education for personal cleanliness.  -Delousing of population by washing facilities & dusting with a suitable insecticide. Specific prevention:  typhus vaccine (live attenuated vaccine), Madrid E typhus vaccine a single IM dose, giving immunity for 5 years. *Cases:  -Notification to LHO.  -Isolation in hospital after dusting.  -Terminal disinfection by dusting (to kill any lice) & steam disinfection for clothes & bedding (to kill rickettsia).  -Treatment by tetracycline 500 mg / 6hs for seven days.  -Release after clinical recovery of the case.
  • 20. *Contacts :-  -Delousing by bathing & dusting.  -Surveillance for 2 weeks, for case-finding. *Epidemic measures :-  -Delousing of confined groups and underdeveloped communities by washing facilities & dusting.  -Vaccination of high risk groups.  -Searching for the source of infection
  • 21. 6-Emad is a cattle merchant return from Brazil from one month he came to hospital with fever, chills, malaise, headache, nausea, lassitude, muscle and joint pain, rigor sensation and the fever rapidly rising ending by profuse sweating. The cycle of fever, chills, sweating is repeated daily
  • 22. a)What’s possible diagnosis?  Possible diagnosis: Malaria b)How to Confirm diagnosis? by:  •Demonstration of malaria parasites in thick blood film.  •Repeated microscopic examination every 12-24 hours may be necessary to  cover all parasite species.  •Several tests have been developed: The most promising are: -Rapid diagnostic tests that detect plasmoidal antigens in the blood. -PCR is the most sensitive method. -Demonstrating antibodies which appear after first week of infection but may persist for years denoting past malaria infection.
  • 23. C) What are the Complications?  -Anemia.  -Splenomegaly.  -Abortion and fetal infection.  -Falciparum malaria may be associated with respiratory distress, jaundice, liver failure, encephalopathy, pulmonary and cerebral edema, coma and death.
  • 24. D)Prevention& Control: 1 .General preventive measures: of arthropod borne disease.  -Environmental sanitation, vector control and Health education: *Elimination of the breeding sites of mosquito by filling of swamps, marches and small collection of water. *Eradication of larval stages by spraying crude oil and larvicides on water surface. *Destruction of adult mosquitoes by using suitable insecticides (liquid aerosol, pyrethrium).  -Human protection: *Screening of windows and doors, using bed nets and animal barrier between breeding places and human habitation. -using protective cloths. -Apply of repellents to exposed skin between dusk -Avoid going outdoors and down when anopheline mosquitoes commonly bite. -Health education of the public, at risk groups and travelers for the mode of transmission, protection from exposure and value of prophylaxis and treatment. -Avoid taking blood from any individual giving history of malaria or a history of travel to, or residence in, a malarious area
  • 25. Specific measures:  Chemoprophylaxis for international travelers going to endemic areas. ■Chloroquine or hydrroxy chloroquine 5 mg /kg /week or chloroquine phosphate (500 mg for average adult). ■The drug must be continued for 4-6 weeks after leaving endemic areas. ■In areas with chloroquine-resistant P. falciparum, mefloquine is recommended (5mg/kg/week) for adults, 1-2 week before travel, during stay and 4 weeks after leaving the endemic area Control:  Case: Early case finding: *By laboratory examination of clinically suspected persons. *By periodic survey. *Through malaria campaign. Treatment: Using antimalarial drugs as chloroquine or mefloquine etc.  Contacts:• Investigation for early case findings.
  • 26. 7-Female child in a village in upper Egypt come with fever, headache, skeletal and abdominal tenderness with palpable liver and spleen, jaundice and purpura occur. Hyperpyrexia, hypotension after examination doctor found lice in her scalp
  • 27. A) what is Possible diagnosis?  LOUSE- BORNE RELAPSING FEVER b) How to Confirm of diagnosis?  by: Dark ground illumination or stained blood films. Intraperitoneal inoculation or culture in lab animals C) what is the Prognosis:  Hyperpyrexia, hypotension and cardiac failure
  • 28. D)What’s the prevention and control? General prevention:  )Delousing by residual insecticide powder as in typhus.  )Protection of susceptible: use of repellents and protective clothes. Specific prevention:  chemoprophylaxis with tetracycline after exposure Control Cases:  Notification : to LHO  Isolation: precautions with blood and body fluids.  Concurrent disinfection : none  Treatment: procaine penicillin injection followed by oral tetracycline Contacts: Case findings. Epidemic measures:  Apply insecticides to clothes and houses